EA Advice

EA Advice is a specialist consultancy dedicated to the design, strategy, and implementation of Early Access Programs (EAPs) and Managed Access Programs (MAPs). The firm supports pharmaceutical and biotechnology companies in navigating the intricate regulatory, legal, and operational challenges associated with providing pre-approval access to medicines. Their services include strategic planning, global regulatory mapping, and the development of robust frameworks for compassionate use and expanded access. By leveraging deep industry expertise, EA Advice helps clients bridge the gap between clinical trials and commercial availability for patients with life-threatening or debilitating conditions. The company operates globally, ensuring that innovative therapies reach those in need while maintaining compliance with international standards.